The Autism Spectrum Quotient (AQ) is a 50-item self-report questionnaire developed by Simon Baron-Cohen and colleagues (2001, Autism Research Centre, University of Cambridge) that measures the degree of autistic traits in adults aged 16 and older with an IQ of 80 or above. The AQ assesses five domains — social skills, attention switching, attention to detail, communication, and imagination — each containing 10 items rated on a 4-point agree/disagree scale. Total scores range from 0 to 50, with a clinical cutoff of 26 for referred populations and 32 for the general population. The AQ demonstrates good test-retest reliability and effectively discriminates between autistic and non-autistic adults (Baron-Cohen et al., 2001). Zentake's digital version provides HIPAA-compliant administration with automated scoring and instant subscale breakdowns.
The AQ uses a binary scoring system applied to a 4-point response format (Definitely Agree, Slightly Agree, Slightly Disagree, Definitely Disagree). For each item, the response is scored as either 0 or 1 point. Whether "agree" or "disagree" responses earn the point depends on the item's directionality — approximately half the items are forward-scored and half are reverse-scored.
Total AQ scores range from 0 to 50, with higher scores indicating a greater degree of autistic traits. The five subscale scores each range from 0 to 10.
Zentake automatically calculates the total AQ score and all five subscale scores upon form submission, presenting results in a clear summary with color-coded threshold indicators.
Step 1: Confirm appropriateness. Verify that the individual is aged 16 or older and has an estimated IQ of 80 or above, as the AQ was validated for this population. Using Zentake, you can send the AQ directly to the individual's email or device before their appointment.
Step 2: Provide clear instructions. Explain that the questionnaire contains 50 statements about everyday preferences and behaviors. Each statement should be answered based on how strongly they agree or disagree. Emphasize there are no right or wrong answers. Zentake's digital form includes built-in instructions for self-administration.
Step 3: Allow self-completion. The AQ is designed as a self-report measure and typically takes 5 to 10 minutes to complete. The individual should answer all 50 items without overthinking. Zentake tracks completion progress and flags any skipped items before submission.
Step 4: Review automatically scored results. Once submitted, Zentake instantly calculates the total score and all five subscale scores. Review the results in the context of the individual's clinical presentation and referral question. Scores at or above the relevant cutoff warrant further diagnostic evaluation.
Step 5: Integrate findings into clinical workflow. Use the AQ results alongside other clinical data to inform diagnostic decisions. Zentake stores all AQ results in the individual's record, enabling comparison across time points and easy sharing with referring clinicians or multidisciplinary team members.
Scoring: Paper AQ requires manual identification of forward- and reverse-scored items, then hand-tallying 50 binary scores across five subscales — a process prone to error. Zentake automatically computes the total score and all five subscale scores instantly upon submission.
Completion: Paper administration takes 5–10 minutes for the respondent, plus 5–10 additional minutes for manual scoring. Zentake maintains the same 5–10 minute completion time while eliminating all scoring labor.
Delivery: Paper forms must be printed, distributed, and collected in person. Zentake delivers the AQ digitally via email, text, or patient portal link, enabling completion before the appointment.
Data Storage: Paper AQ forms require physical filing and secure storage to meet privacy requirements. Zentake stores all data in encrypted, HIPAA-compliant cloud infrastructure with automatic backups.
Longitudinal Tracking: Comparing paper AQ results over time requires manually retrieving and reviewing previous forms. Zentake displays score trends across all administrations in a single dashboard view.
Security: Paper forms can be misplaced or accessed by unauthorized individuals. Zentake uses encryption at rest and in transit, role-based access controls, and comprehensive audit logging.
Integration: Paper results must be manually entered into electronic health records. Zentake integrates directly with EMR systems, pushing completed assessment data without manual re-entry.
Cost: Paper administration involves ongoing printing and administrative labor costs. Zentake eliminates physical supply expenses through digital automation.
What does the Autism Spectrum Quotient measure?
The AQ measures the degree of autistic traits across five domains: social skills, attention switching, attention to detail, communication, and imagination. It quantifies where an individual falls on the autism spectrum in terms of trait expression, rather than providing a binary diagnosis. Higher scores indicate a greater number of autistic traits. Zentake provides instant domain-level breakdowns to support clinical interpretation.
How do you score the Autism Spectrum Quotient?
Each of the 50 items is scored as 0 or 1 based on whether the response aligns with the autistic trait direction. Items are split between forward-scored (where "agree" earns the point) and reverse-scored (where "disagree" earns the point). The total score ranges from 0 to 50. Zentake handles all scoring logic automatically and presents total and subscale results immediately upon submission.
How long does the AQ take to complete?
The AQ typically takes 5 to 10 minutes to complete as a self-report questionnaire. Respondents should answer based on initial impressions without overthinking. Zentake's digital format tracks completion progress and flags any unanswered items before final submission.
Is the Autism Spectrum Quotient free to use?
Yes, the AQ is freely available for clinical and research use. The original questionnaire was published by Baron-Cohen et al. (2001) and can be downloaded from the Autism Research Centre at the University of Cambridge. Zentake offers a ready-to-use digital version as part of its template library, available through a free trial.
What age group is the AQ designed for?
The AQ is designed for adults and adolescents aged 16 and older with an IQ of 80 or above. For younger populations, the AQ-10 Adolescent (ages 12–15) and AQ-10 Child versions are available. All age-specific versions can be accessed through Zentake's template library.
Who should administer the Autism Spectrum Quotient?
The AQ is a self-report measure that can be completed independently by the individual being assessed. However, the results should be interpreted by a qualified clinician — typically a psychologist, psychiatrist, or other mental health professional experienced in autism spectrum conditions. Zentake supports both clinician-guided and self-directed administration modes.
What is a clinically significant AQ score?
A score of 32 or above is considered clinically significant in general population screening, as 80% of individuals with diagnosed autism spectrum conditions score at or above this threshold. For individuals already referred for clinical assessment, a lower cutoff of 26 is recommended. Zentake displays color-coded threshold indicators alongside results to aid clinical decision-making.
Can the AQ diagnose autism?
No. The AQ is a screening tool that measures autistic traits, not a diagnostic instrument. A high AQ score indicates the presence of traits associated with autism and suggests that further comprehensive diagnostic evaluation is warranted. Diagnosis requires a full clinical assessment by a qualified professional. Zentake clearly labels AQ results as screening outcomes to support appropriate clinical use.
1. Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The Autism-Spectrum Quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17.
2. Woodbury-Smith, M. R., Robinson, J., Wheelwright, S., & Baron-Cohen, S. (2005). Screening adults for Asperger syndrome using the AQ: A preliminary study of its diagnostic validity in clinical practice. Journal of Autism and Developmental Disorders, 35(3), 331–335.
3. Ruzich, E., Allison, C., Smith, P., Watson, P., Auyeung, B., Ring, H., & Baron-Cohen, S. (2015). Measuring autistic traits in the general population: A systematic review of the Autism-Spectrum Quotient (AQ) in a nonclinical population sample of 6,900 typical adult males and females. Molecular Autism, 6, 2.
Last updated: March 2026
The leading patient intake platform. HIPAA compliant forms for healthcare providers and organizations. Find out what you're missing!
